Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis
Diabetes · 01.10.2025 · 74 (10) · 1787-1801
DOI: 10.2337/db25-0209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 25.08.2025. Verfasst von Tessa M Cacciottolo und 18 weiteren Autor:innen. Beteiligte Einrichtung: University of Cambridge Metabolic Research Laboratories and National Institute for Health Research Cambridge Biomedical Research Centre, Institute of…. Hauptthemen laut MEDLINE: Fatty Liver, Receptors, Glucagon. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
In mice, glucagon regulates lipid metabolism by activating receptors in the liver; however, its role in human lipid metabolism is incompletely understood. Here we describe three normal-weight individuals from a consanguineous family with early-onset hepatic steatosis and/or cirrhosis. Using exome sequencing, we found they were homozygous for two missense variants in the glucagon receptor gene (GCGR). In cells, the double GCGR mutation reduced cell membrane expression and signaling, resulting in an almost complete loss of function. Carriers of pathogenic GCGR mutations had substantially elevated circulating glucagon and amino acid levels and increased adiposity. Introducing the double GCGR mutation into human induced pluripotent stem cell–derived hepatocytes using CRISPR/Cas9 caused increased lipid accumulation. Our results provide an explanation for increased liver fat seen in clinical trials of GCGR antagonists and reduced liver fat in people with obesity and steatotic liver disease treated with GCGR agonists. Article Highlights In this study, we investigated a consanguineous family in whom normal-weight individuals had hepatic steatosis and cirrhosis. Using whole-exome sequencing we found two rare homozygous variants in the glucagon receptor (GCGR) gene that cosegregated with the phenotype. In cells, the GCGR mutations result in a loss of function and increased lipid accumulation. These results highlight the potential risks associated with GCGR antagonists and the benefits of GCGR agonists, currently in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Cambridge Metabolic Research Laboratories and National Institute for Health Research Cambridge Biomedical Research Centre, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K.
- Department of Metabolism, Digestion & Reproduction, Imperial College London, London, U.K.
- Department of Gastroenterology and Hepatology, Royal Berkshire National Health Service Foundation Trust, Reading, U.K.
- Department of Histopathology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, U.K.
- Department of Radiology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, U.K.
- National Institute for Health Research Clinical Research Facility, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, U.K.
ORCID-Profile: I Sadaf Farooqi
Förderung
- Wellcome Trust
Zitieren
APA
Cacciottolo, T. M., Lawler, K., Méndez-Acevedo, K. M., Mendes de Oliveira, E., Syanda, A., Henning, E., Keogh, J. M., Bounds, R., Smith, M., Ashraf, D., Harman, D., Duckworth, A., Godfrey, E. M., Watson, L., Hoare, M., Jones, B., Baker, A., Rashid, T., & Farooqi, I. S. (2025). Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis. Diabetes, 74(10), 1787-1801. https://doi.org/10.2337/db25-0209
Vancouver
Cacciottolo TM, Lawler K, Méndez-Acevedo KM, Mendes de Oliveira E, Syanda A, Henning E, et al. Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis. Diabetes. 2025;74(10):1787-1801. doi:10.2337/db25-0209
BibTeX
@article{Cacciottolo2025,
author = {Cacciottolo, Tessa M and Lawler, Katherine and Méndez-Acevedo, Kevin M and Mendes de Oliveira, Edson and Syanda, Adam and Henning, Elana and Keogh, Julia M and Bounds, Rebecca and Smith, Miriam and Ashraf, Daniyal and Harman, David and Duckworth, Adam and Godfrey, Edmund M and Watson, Laura and Hoare, Matthew and Jones, Ben and Baker, Alastair and Rashid, Tamir and Farooqi, I Sadaf},
title = {Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {10},
pages = {1787--1801},
doi = {10.2337/db25-0209}
}
EUVIMED